Results 31 to 40 of about 1,453 (114)

Efficacy and safety of established and off‐label ADHD drug therapies for cognitive impairment or attention‐deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force

Bipolar Disorders, Volume 26, Issue 3, Page 216-239, May 2024.
Abstract Background Abnormalities in dopamine and norepinephrine signaling are implicated in cognitive impairments in bipolar disorder (BD) and attention‐deficit hyperactivity disorder (ADHD). This systematic review by the ISBD Targeting Cognition Task Force therefore aimed to investigate the possible benefits on cognition and/or ADHD symptoms and ...
Kamilla W. Miskowiak, Zacharias K. Obel, Riccardo Guglielmo, Caterina del Mar Bonnin, Christopher R. Bowie, Vicent Balanzá‐Martínez, Katherine E. Burdick, Andre F. Carvalho, Annemieke Dols, Katie Douglas, Peter Gallagher, Lars V. Kessing, Beny Lafer, Kathryn E. Lewandowski, Carlos López‐Jaramillo, Anabel Martinez‐Aran, Roger S. McIntyre, Richard J. Porter, Scot E. Purdon, Ayal Schaffer, Paul R. A. Stokes, Tomiki Sumiyoshi, Ivan J. Torres, Tamsyn E. Van Rheenen, Lakshmi N. Yatham, Allan H. Young, Eduard Vieta, Gregor Hasler   +27 more
wiley   +1 more source

Patterns of pharmacotherapy for bipolar disorder: A GBC survey

Bipolar Disorders, Volume 26, Issue 1, Page 22-32, February 2024.
Abstract Objectives To understand treatment practices for bipolar disorders (BD), this study leveraged the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic treatment patterns in multiple cohorts of well‐characterized individuals with BD in North America, Europe, and Australia. Methods Data on pharmacotherapy, demographics,
Balwinder Singh, Anastasia K. Yocum, Rebecca Strawbridge, Katherine E. Burdick, Caitlin E. Millett, Amy T. Peters, Sarah H. Sperry, Giovanna Fico, Eduard Vieta, Norma Verdolini, Ophelia Godin, Marion Leboyer, Bruno Etain, Ivy F. Tso, Brandon J. Coombes, Melvin G. McInnis, Andrew A. Nierenberg, Allan H. Young, Melanie M. Ashton, Michael Berk, Lana J. Williams, Kamyar Keramatian, Lakshmi N. Yatham, Bronwyn J. Overs, Janice M. Fullerton, Gloria Roberts, Philip B. Mitchell, Ole A. Andreassen, Ana C. Andreazza, Peter P. Zandi, Daniel Pham, Joanna M. Biernacka, Mark A. Frye, The FACE‐BD Collaborators, The Global Bipolar Cohort Collaborative, Valérie Aubin, Raoul Belzeaux, Caroline Dubertret, Sebastien Gard, Emmanuel Haffen, Emilie Olie, Christine Passerieux, Mircea Polosan, Raymund Schwan, Ludovic Samalin   +44 more
wiley   +1 more source

Challenges in defining treatment‐resistant mania in adults: A systematic review

Bipolar Disorders, Volume 26, Issue 1, Page 7-21, February 2024.
Abstract Objectives To review the definitions of treatment‐resistant mania (TRM) in the literature and propose criteria for an operationalized definition. Methods A systematic search of five databases (MEDLINE, EMBASE, PsychInfo, Cochrane Central, and CINAHL) and data extraction of eligible articles. Results In total, 47 articles addressing the concept
Christina Gonzalez‐Torres, Benoit H. Mulsant, M. Ishrat Husain, Martin Alda, Robert C. Young, Abigail Ortiz   +5 more
wiley   +1 more source

Discovery Patterns of Drugs Approved for Treating Bipolar Disorder by Applying Operational Criteria of Serendipity: A Historical Analysis

Mental Illness, Volume 2024, Issue 1, 2024.
While the scientific community has long acknowledged the significant role of serendipity in shaping the field of contemporary psychopharmacology, its impact has not undergone a comprehensive analysis using operational methodologies. Serendipity, originally defined as discoveries stemming from a blend of luck and astuteness by Walpole, has been ...
Francisco López-Muñoz, Pilar D’Ocón, Alejandro Romero, José A. Guerra, Domenico De Berardis, Cecilio Álamo, Giuseppe Tavormina   +6 more
wiley   +1 more source

Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran

Neuropsychiatric Disease and Treatment, 2008
Naghmeh Mokhber1, Carol J Lane2, Mohamad R Azarpazhooh3, Elham Salari4, Reza Fayazi5, Mohamad T Shakeri6, Allan H Young71Assistant Professor of Psychiatry, 3Assistant Professor of Neurology, 4Mashhad Department of Forensic Psychiatry, 5Assistant ...
Naghmeh Mokhber, Carol J Lane, Mohamad R Azarpazhooh, Elham Salari, Reza Fayazi, et al   +5 more
doaj  

BLUES - stabilizing mood and sleep with blue blocking eyewear in bipolar disorder - a randomized controlled trial study protocol. [PDF]

Ann Med, 2023
Madsen HØ, Hageman I, Martiny K, Faurholt-Jepsen M, Kolko M, Henriksen TEG, Kessing LV.   +6 more
europepmc   +1 more source

Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence. [PDF]

Neuropharmacology, 2023
Daniels SD, Boison D.
europepmc   +1 more source

Exploring Secondary Mania: A Case of Medial Frontal Meningioma With Exceptional Response to Antimanic Medication. [PDF]

Neuropsychopharmacol Rep
Shen YC, Su HY.
europepmc   +1 more source

Managing Impulsivity and Substance Abuse in an Adolescent with Attention-deficit Hyperactivity Disorder: Potential for Endoxifen Therapy. [PDF]

Indian J Psychol Med
Banerjee D.
europepmc   +1 more source

Managing bipolar affective disorder in chronic kidney disease when lithium is no longer an option. [PDF]

BMJ Case Rep
Corrigan K, Larkin D, Gallagher M, Guerandel A.   +3 more
europepmc   +1 more source